Visalytics
Visalytics
approved EB-2 (NIW)

Senior Scientist

Molecular Biology · Bangladesh · 2022-04-19

Processing Time
180 days
Decision Date
2022-04-19
Location
Alabama
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research on the production of novel, targeted drug delivery options for cancer immunotherapy. This work focuses on developing targeting peptides as low-cost, effective antitumor treatments to improve patient outcomes and cancer care standards, specifically for prostate cancer.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses cancer, a leading cause of death in the U.S., and offers potential for low-cost, effective treatments.

2 Well-positioned to Advance the Endeavor Met

The petitioner's academic background and record of 109 citations demonstrate significant influence in the field.

3 Waiver of Job Offer and Labor Certification Met

The national interest in improving cancer care and the support from federal funding agencies justify the waiver.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in integrative bioscience and a record of 4 peer-reviewed journal articles and 2 peer-reviewed abstracts. His work earned 109 citations and was supported by 4 expert recommendation letters and significant funding from major federal agencies including the NIH and DOD.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
Pennsylvania 8 days 2025-02-05
The petitioner proposes to engineer immune cells and design tumor-targeting therapies using novel immunotherapy approaches, such as lentiviral systems. The work focuses on developing conditionally dependent peptides that target tumors with high precision to enhance treatment effectiveness. The goal is to create next-generation treatment strategies that reduce cancer relapse and minimize side effects for patients.
View Case

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Maryland 289 days 2025-02-26
The petitioner proposes to continue her research in biotechnology, specifically developing novel combinatorial chemotherapies, immunotherapies, and plasma-based prognostic markers for cancer treatment. Her work focuses on investigating cancer signaling pathways and immune checkpoint regulation to enhance therapeutic efficacy and support personalized oncology care.
View Case

Research Scientist

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
Maryland 470 days 2025-02-28
The petitioner proposes to continue research in molecular biology focusing on the roles of specific proteins and signaling pathways in cancer development. The work involves studying compounds that disrupt survival signals in cancer cells to design highly effective, targeted therapies. The goal is to improve patient survival rates and enhance the precision of cancer treatments globally.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 124 days 2023-01-25
The petitioner proposes to continue developing state-of-the-art agonistic onco-immunologic approaches for therapeutic applications to progress next-generation tumor treatment, specifically targeting advanced and metastatic late-stage tumors. The work utilizes therapeutic cellular engineering and biologics techniques to improve cancer immunotherapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Bangladesh

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-04-19.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 180 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Bangladesh All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist